Holen Sie sich die Stockscreener-App
4.43
3.26%
0.14
Handel nachbörslich:
4.32
-0.11
-2.48%
Schlusskurs vom Vortag:
$4.29
Offen:
$4.27
24-Stunden-Volumen:
88,626
Relative Volume:
0.63
Marktkapitalisierung:
$20.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.69M
KGV:
-1.9013
EPS:
-2.33
Netto-Cashflow:
$-3.81M
1W Leistung:
+6.75%
1M Leistung:
-16.73%
6M Leistung:
+254.40%
1J Leistung:
+119.31%
1-Tages-Spanne:
$4.235
$4.5102
1-Wochen-Bereich:
$4.05
$4.55
52-Wochen-Spanne:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Firmenname
Lixte Biotechnology Holdings Inc
Sektor
Branche
Telefon
310 203 2902
Adresse
248 ROUTE 25A, EAST SETAUKET
Vergleichen Sie LIXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.43 | 24.47M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Why Lixte Biotechnology Holdings Inc. stock remains resilientProduct Launch & Daily Profit Maximizing Tips - newser.com
How to use a screener to detect Lixte Biotechnology Holdings Inc. breakouts2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com
Will Lixte Biotechnology Holdings Inc. stock attract ESG investors2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant showing signs of accumulationJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Market reaction to Lixte Biotechnology Holdings Inc.’s recent news2025 Momentum Check & Technical Pattern Recognition Alerts - newser.com
What recovery options are there for Lixte Biotechnology Holdings Inc. Equity WarrantTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
Will Lixte Biotechnology Holdings Inc. (8640) stock rise with strong economy2025 Short Interest & Daily Profit Focused Screening - newser.com
Key metrics from Lixte Biotechnology Holdings Inc.’s quarterly dataPortfolio Value Summary & High Conviction Investment Ideas - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock reversal real or fakeLayoff News & Expert Approved Momentum Trade Ideas - newser.com
What hedge fund activity signals for Lixte Biotechnology Holdings Inc. Equity Warrant stockSell Signal & Growth Focused Entry Reports - newser.com
Is it time to cut losses on Lixte Biotechnology Holdings Inc.Product Launch & Comprehensive Market Scan Reports - newser.com
How Lixte Biotechnology Holdings Inc. Equity Warrant stock compares to market leadersLayoff News & Free Technical Confirmation Trade Alerts - newser.com
How Lixte Biotechnology Holdings Inc. stock benefits from tech adoptionGap Up & Community Shared Stock Ideas - newser.com
How Lixte Biotechnology Holdings Inc. Equity Warrant stock reacts to bond yieldsBear Alert & Detailed Earnings Play Strategies - newser.com
Sector ETF performance correlation with Lixte Biotechnology Holdings Inc.2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Published on: 2025-11-03 02:18:09 - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant trending in predictive chart modelsWatch List & Stepwise Trade Signal Guides - newser.com
Published on: 2025-11-03 00:50:13 - newser.com
How institutional buying supports Lixte Biotechnology Holdings Inc. stockMarket Risk Report & Safe Entry Momentum Stock Tips - newser.com
Reversal indicators forming on Lixte Biotechnology Holdings Inc. stockM&A Rumor & Safe Entry Trade Reports - newser.com
Published on: 2025-11-02 22:31:07 - newser.com
Published on: 2025-11-02 21:13:04 - newser.com
Is Lixte Biotechnology Holdings Inc. stock attractive after correctionRisk Management & Weekly High Conviction Ideas - newser.com
Should you wait for a breakout in Lixte Biotechnology Holdings Inc. Equity Warrant - newser.com
Custom strategy builders for tracking Lixte Biotechnology Holdings Inc. Equity WarrantQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Why Lixte Biotechnology Holdings Inc. stock is trending among retail tradersBond Market & Long Hold Capital Preservation Tips - newser.com
Lixte Biotechnology Holdings Inc. stock momentum explainedEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com
Published on: 2025-11-02 04:52:31 - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant a candidate for recovery play2025 Risk Factors & Long-Term Safe Investment Plans - newser.com
Real time social sentiment graph for Lixte Biotechnology Holdings Inc. Equity WarrantPortfolio Update Summary & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-02 04:25:32 - newser.com
How hedge fund analytics apply to Lixte Biotechnology Holdings Inc. Equity Warrant stockLong Setup & Risk Controlled Daily Trade Plans - newser.com
Is Lixte Biotechnology Holdings Inc. (8640) stock undervalued after correctionTrade Volume Summary & Free Fast Entry Momentum Trade Alerts - newser.com
Will Lixte Biotechnology Holdings Inc. (8640) stock benefit from sector leadershipTrade Volume Report & Capital Protection Trade Alerts - newser.com
Published on: 2025-11-01 22:25:23 - newser.com
Published on: 2025-11-01 12:34:14 - newser.com
Will Lixte Biotechnology Holdings Inc. Equity Warrant stock deliver consistent dividends2025 Market Outlook & Expert Curated Trade Setups - newser.com
Predicting Lixte Biotechnology Holdings Inc. Equity Warrant trend using moving averagesGap Up & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-11-01 06:44:57 - newser.com
Is Lixte Biotechnology Holdings Inc. stock poised for growthQuarterly Trade Summary & Verified Entry Point Signals - newser.com
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):